Booz Allen's Q4 Earnings Surpass Estimates, Increase Y/Y

Booz Allen Hamilton (BAH) reported mixed fiscal Q4 2025 results, with adjusted EPS of $1.61 beating estimates by 1.3% and increasing 21.1% year-over-year, while revenues of $2.3 billion missed estimates by 1.5% but increased 7.3% year-over-year. The total backlog increased 14.8% to $37 billion, though this missed estimates. For fiscal year 2026, BAH projects revenue between $12-$12.5 billion, representing growth of 0-4%, and adjusted EPS between $700-$800 million.

Analysis

Booz Allen Hamilton (BAH) reported mixed fourth-quarter fiscal 2025 results. Adjusted earnings per share reached $1.61, surpassing the Zacks Consensus Estimate by 1.3% and increasing 21.1% year-over-year. However, revenues of $2.3 billion missed the consensus by 1.5%, despite a 7.3% year-over-year rise; revenues excluding billable expenses grew 6.2% to $2.05 billion. The market showed a muted response to these figures, with no stock price change post-release. A key positive was the 14.8% year-over-year growth in total backlog to $37 billion, accompanied by an improved book-to-bill ratio of 1.39, up from 1.22. Nevertheless, this total backlog, along with its funded ($4.4 billion, up 5.6% YoY) and unfunded ($8.8 billion, up 4.9% YoY) components, as well as priced options ($23.8 billion, up 21.9% YoY), fell short of internal estimates. Headcount saw a 4.4% year-over-year increase to 35,800. Adjusted EBITDA grew 11.9% to $1.32 billion, aligning with estimates, while the adjusted EBITDA margin on revenues remained flat at 11%. The company's balance sheet showed $885 million in cash and cash equivalents, a significant increase from the previous year, but long-term debt also rose by 16.9% to $3.9 billion. Booz Allen reported $218 million in net cash from operating activities, capital expenditure of $1.2 billion, and free cash flow of $911 million for the quarter. For fiscal 2026, BAH guided for revenues between $12-$12.5 billion, implying a 0-4% growth rate, a notable deceleration. The company also projected an adjusted EPS of $700-$800 million and capital expenditures of approximately $110 million.

Key Decisions for Investors

• Investors should weigh Booz Allen's strong 21.1% year-over-year adjusted EPS growth and 14.8% backlog increase against the Q4 revenue miss, backlog estimate shortfalls, and the market's neutral reaction before making investment decisions.
• Closely monitor the company's ability to convert its $37 billion backlog into realized revenue, particularly as the FY26 revenue growth guidance of 0-4% signals a significant slowdown from the 7.3% growth reported in Q4 FY25.
• Assess the implications of the 16.9% year-over-year increase in long-term debt to $3.9 billion, and critically examine the reported Q4 capital expenditure of $1.2 billion and free cash flow of $911 million relative to operating cash flows for sustainability.
• Carefully evaluate the fiscal 2026 adjusted EPS guidance of $700-$800 million, scrutinizing its underlying assumptions and potential impact on valuation, especially in the context of modest revenue growth projections.